Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Barbara Jennings"'
Publikováno v:
Journal of Allergy and Clinical Immunology. 102:363-367
Background: A simple laboratory method to evaluate relative potency of inhaled corticosteroids in asthma would be valuable. Single-dose studies with the allergen-induced late asthmatic response have failed to show a useful dose-response relationship.
Autor:
Choudry N, Kidney Jc, Paul M. O'Byrne, Barbara Jennings, Donald W. Cockcroft, L.-P. Boulet, Andersson N, M M Morris, Veronica A. Swystun, Francine Deschesnes, F. E. Hargreave, Andreasson A
Publikováno v:
Journal of Allergy and Clinical Immunology. 100:65-70
Inhaled corticosteroids are the most commonly used antiinflammatory agents for asthma. There is no simple way to compare objectively the relative potency of inhaled corticosteroids. The allergen-induced late asthmatic response (LAR) can be suppressed
Publikováno v:
Journal of Allergy and Clinical Immunology. 99:186-193
To determine therapeutically and systemically equivalent dosages of budesonide inhaled through the Turbuhaler dry powder inhalation device (Astra Pharma Production AB, Sodertalje, Sweden) or pressurized metered-dose inhaler (pMDI) plus Nebuhaler spac
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 72:530-540
Inhaled glucocorticosteroids have been developed for the treatment of asthma in an attempt to minimize the suppression of endogenous adrenal function that complicates oral or injected steroid usage, but it is unclear whether this strategy leads to re
Publikováno v:
The Journal of allergy and clinical immunology. 88(4)
To assess whether the use of larger than usual doses of inhaled steroid to treat severe asthma may adversely affect bone turnover and whether such an effect may be mitigated by altering the dose schedule, we investigated the effects of budesonide (BU
Autor:
O Borga, J. Baskerville, Barbara Jennings, J.H. Toogood, Neville M. Lefcoe, C W Frankish, S.A. Johansson
Publikováno v:
The Journal of allergy and clinical immunology. 85(5)
Inhaled antiasthmatic steroids have been assumed and yet never proved to exert their antiasthmatic effect by topical action in the airways. We tested the hypothesis that the efficacy of inhaled budesonide (BUD) might be due instead to its systemic ac
Publikováno v:
The Journal of allergy and clinical immunology. 84(5 Pt 1)
We determined the relative antiasthmatic and systemic glucocorticoid potencies of inhaled budesonide (BUD) versus morning-dose oral prednisone (PRED) in 34 adult patients with asthma over a dose range extending from conventional to high and potential